FI912995A0 - ATIATEROSKLEROTISKA OCH ANTIROMBOTISKA 1-BENZOPYRAN-4-ONER OCH 2-AMINO-1,3-BENZOXAZIN-4-ONER. - Google Patents

ATIATEROSKLEROTISKA OCH ANTIROMBOTISKA 1-BENZOPYRAN-4-ONER OCH 2-AMINO-1,3-BENZOXAZIN-4-ONER.

Info

Publication number
FI912995A0
FI912995A0 FI912995A FI912995A FI912995A0 FI 912995 A0 FI912995 A0 FI 912995A0 FI 912995 A FI912995 A FI 912995A FI 912995 A FI912995 A FI 912995A FI 912995 A0 FI912995 A0 FI 912995A0
Authority
FI
Finland
Prior art keywords
oner
och
atiaterosklerotiska
antirombotiska
benzoxazin
Prior art date
Application number
FI912995A
Other languages
Finnish (fi)
Inventor
Ronald B Gammill
Thomas M Judge
Joel Morris
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI912995A0 publication Critical patent/FI912995A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI912995A 1988-12-21 1991-06-19 ATIATEROSKLEROTISKA OCH ANTIROMBOTISKA 1-BENZOPYRAN-4-ONER OCH 2-AMINO-1,3-BENZOXAZIN-4-ONER. FI912995A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28779688A 1988-12-21 1988-12-21
PCT/US1989/005526 WO1990006921A1 (en) 1988-12-21 1989-12-15 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones

Publications (1)

Publication Number Publication Date
FI912995A0 true FI912995A0 (en) 1991-06-19

Family

ID=23104392

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912995A FI912995A0 (en) 1988-12-21 1991-06-19 ATIATEROSKLEROTISKA OCH ANTIROMBOTISKA 1-BENZOPYRAN-4-ONER OCH 2-AMINO-1,3-BENZOXAZIN-4-ONER.

Country Status (8)

Country Link
EP (1) EP0459983A1 (en)
JP (1) JPH04502322A (en)
AU (1) AU634994B2 (en)
DK (1) DK118791D0 (en)
FI (1) FI912995A0 (en)
HU (2) HUT58310A (en)
RU (1) RU2118321C1 (en)
WO (1) WO1990006921A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05509302A (en) * 1990-06-20 1993-12-22 ジ・アップジョン・カンパニー Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazin-4-ones
US5302613A (en) * 1990-06-29 1994-04-12 The Upjohn Company Antiatheroscleroic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones
US5252735A (en) * 1990-06-29 1993-10-12 The Upjohn Company Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones
AU630822B2 (en) * 1990-06-29 1992-11-05 Upjohn Company, The Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones
IL112764A0 (en) * 1994-03-18 1995-05-26 Ferrer Int New chromene derivatives
CA2182932A1 (en) * 1995-08-10 1997-02-11 Koju Watanabe Chromone derivative, process for preparing same and pharmaceutical composition
DE19850131A1 (en) * 1998-10-30 2000-05-04 Merck Patent Gmbh Chromenon and chromanone derivatives
WO2000051992A1 (en) * 1999-03-04 2000-09-08 E.I. Du Pont De Nemours And Company Fused bicyclic oxazinone and thiazinone fungicides
CA2398163C (en) * 2000-01-24 2011-02-22 Kinacia Pty Ltd. Therapeutic morpholino-substituted compounds
GB0119863D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119865D0 (en) * 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
US7049313B2 (en) 2002-02-25 2006-05-23 Kudos Pharmaceuticals Ltd. ATM inhibitors
CA2482041C (en) 2002-04-17 2012-06-05 Cytokinetics, Inc. 4-chromanone derivatives for treating cellular proliferative diseases and disorders
AU2003252025A1 (en) 2002-07-17 2004-02-02 Cytokinetics, Inc. Compounds, compositions, and methods
NZ538420A (en) 2002-08-16 2007-06-29 Kinacia Pty Ltd Inhibition of phosphoinositide 3-kinase beta
CN100430389C (en) * 2002-08-16 2008-11-05 阿斯利康(瑞典)有限公司 Inhibition of phsphoinostide 3-dinase beta
ATE459359T1 (en) * 2003-06-06 2010-03-15 Arexis Ab USE OF CONDENSED HETEROCYCLIC COMPOUNDS AS SCCE INHIBITORS FOR THE TREATMENT OF SKIN CONDITIONS
CN100518740C (en) * 2003-06-06 2009-07-29 阿里克斯股份公司 Use of heterocyclic compounds as SCCE inhibitors
KR20060066722A (en) 2003-08-13 2006-06-16 쿠도스 파마슈티칼스 리미티드 Aminopyrones and their use as atm inhibitors
TR200808208T1 (en) * 2003-12-09 2008-12-22 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Suppression of an immune response or treatment of a proliferative disease
TW200616986A (en) 2004-09-20 2006-06-01 Kudos Pharm Ltd DNA-pk inhibitors
EP1848712A1 (en) 2005-02-09 2007-10-31 Kudos Pharmaceuticals Ltd Atm inhibitors
AR054438A1 (en) 2005-04-15 2007-06-27 Kudos Pharm Ltd DNA INHIBITORS -PK
WO2009038064A1 (en) * 2007-09-19 2009-03-26 Institute Of Medicinal Molecular Design, Inc. Heterocyclic derivative having inhibitory activity on type-i 11β-hydroxysteroid dehydrogenase
CN102227417B (en) * 2008-09-29 2015-09-16 西特里斯药业公司 As the chromene keto analog of Sirtuin conditioning agent
US8399460B2 (en) 2009-10-27 2013-03-19 Astrazeneca Ab Chromenone derivatives
UY34013A (en) 2011-04-13 2012-11-30 Astrazeneca Ab ? CHROMENONE COMPOUNDS WITH ANTI-TUMORAL ACTIVITY ?.
RU2468018C1 (en) * 2011-10-06 2012-11-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Российский университет дружбы народов" (РУДН) Method of producing 4-oxo-4h-chromene derivatives containing vinyl and enamine groups
JP6000986B2 (en) * 2012-01-26 2016-10-05 第一三共株式会社 Chromone derivative with bone formation promoting action
WO2014030688A1 (en) * 2012-08-24 2014-02-27 第一三共株式会社 Chromone derivative having linear side chain
CN105142629B (en) 2013-03-04 2018-11-23 阿斯利康(瑞典)有限公司 It is treated in combination
CN108947952B (en) * 2017-05-24 2021-09-21 中国医学科学院药物研究所 2-substituted amino-5-trifluoromethyl-8-nitrobenz (thio) pyran-4-ketone compound and preparation method and application thereof
CN108929329B (en) * 2017-05-24 2020-12-11 中国医学科学院药物研究所 2-azacyclo-5-trifluoromethyl-8-nitrobenz (thio) pyran-4-ones
AR121719A1 (en) 2020-04-03 2022-06-29 Petra Pharma Corp ALLESTERIC INHIBITORS OF CHROMENONE OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASES
IL307950A (en) 2021-05-03 2023-12-01 Petra Pharma Corp Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease
BR112023022890A2 (en) 2021-05-27 2024-01-23 Petra Pharma Corp ALLOSTERIC PHOSPHOINOSITIDE 3-KINASE (PI3K) CHROMENONE INHIBITORS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USES THEREOF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2205913A1 (en) * 1972-02-08 1973-08-16 Thiemann Chem Pharm Fab 2-AMINO-3-HYDROXY-CHROMONE DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE2555290A1 (en) * 1975-12-09 1977-06-16 Boehringer Mannheim Gmbh NEW BENZOPYRONE DERIVATIVES AND METHOD FOR THEIR PRODUCTION
US4412071A (en) * 1982-05-17 1983-10-25 The Upjohn Company Antiatherosclerotic compositions
ZA873745B (en) * 1986-06-04 1988-10-26 Daiichi Seiyaku Co Benzopyran derivatives
MA21528A1 (en) * 1988-04-06 1989-12-31 Lipha SUBSTITUTE COMPONENTS OF FLAVONOIDE, THEIR SALTS, THEIR MANUFACTURES AND PRODUCTS CONTAINING THESE MATERIALS.

Also Published As

Publication number Publication date
DK118791A (en) 1991-06-19
EP0459983A1 (en) 1991-12-11
JPH04502322A (en) 1992-04-23
HUT58310A (en) 1992-02-28
WO1990006921A1 (en) 1990-06-28
AU634994B2 (en) 1993-03-11
DK118791D0 (en) 1991-06-19
AU4807190A (en) 1990-07-10
HU211339A9 (en) 1995-11-28
RU2118321C1 (en) 1998-08-27
HU900394D0 (en) 1991-09-30

Similar Documents

Publication Publication Date Title
FI912995A0 (en) ATIATEROSKLEROTISKA OCH ANTIROMBOTISKA 1-BENZOPYRAN-4-ONER OCH 2-AMINO-1,3-BENZOXAZIN-4-ONER.
FI895047A0 (en) TIENOPYRIDINER, DERAS FRAMSTAELLNING, MELLANPRODUKTER OCH PHARMACEUTISKA SAMMANSAETTNINGAR INNEHAOLLANDE DESSA FOERENINGAR.
FI894395A (en) ANORDNING OCH FOERFARANDE FOER MAETNING AV SVAGA, ORTS- OCH TIDSBEROENDE MAGNETFAELT.
FI895845A0 (en) ENZYMHAEMMANDE UREADERIVAT AV DIPEPTIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE AEMNEN OCH DERAS ANVAENDNING.
FI893546A0 (en) FOERFARANDE FOER TILLVERKNING OCH FOERPACKNING AV EN FICKDISTRIBUTOER, MOTSVARANDE UNDERENHETER OCH DISTRIBUTOERER.
FI896275A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV KATJONAKTIVA AKRYLAMIDPOLYMERER, KATJONAKTIVA AKRYLAMIDPOLYMERER OCH TILLAEMPNING AV DESAMMA.
FI895515A0 (en) ANSLUTNINGSANORDNING FOER HANDTAG, SAERSKILT I SKIDSTAVAR, OCH ANVAENDARENS HAND.
FI892874A0 (en) FLERA LAEGEN INTAGANDE, VIKBAR LAENSTOL MED JUSTERBAR RYGGSTOEDLUTNING OCH SITSHOEJD.
FI892583A0 (en) MJUKGOERINGSMEDEL FOER TEXTILER, VILKA INNEHAOLLER BLANDNINGAR AV SUBSTITUERADE IMIDAZOLINESTRAR OCH KVATERNISERADE ESTERAMMONIUMSALTER.
FI893832A (en) FUSIONERADE TETRAHYDROPYRIDINAETTIKSSYRADERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH ANVAENDNINGEN AV SAODANA FOERENINGAR FOER HJAERTPROTEKTION.
FI885593A (en) FOERFARANDE OCH ANORDNING FOER LAGRING AV HYDRATBILDANDE, GASFORMIGA KOLVAETEN.
FI895285A0 (en) ANTIMIKROBIELLA FOERENINGAR, FOERFARANDE FOER FRAMSTAELLNING DAERAV, KOMPOSITIONER INNEHAOLLANDE DESAMMA OCH ANVAENDNING AV DESSA.
FI894089A0 (en) STABILA KONCENTRATKOMPOSITIONER OCH EMULSIONER AV VATTENOLOESLIGA ORGANISKA PESTICIDER, ANVAENDNING OCH FRAMSTAELLNING AV DESAMMA.
FI895965A0 (en) FOERFARANDE OCH ANORDNING FOER AOSTADKOMMANDE AV VAELVDA, HAERDADE GLASPARTIER FOER BILAR.
FI891061A (en) KINOLINFOERENINGAR KONDENSERADE, AKRIDINFOERENINGAR KONDENSERADE, FOERFARANDE FOER FRAMSTAELLNING DAERAV OCH KARSINOSTATISKA KOMPOSITIONER INNEHAOLLANDE DESAMMA.
FI902818A0 (en) ANORDNING FOER FARTYG FOER UPPTAGNING OCH NEDSAETTNING FRAON FARTYG AV FLYTANDE OCH NEDSAENKBARA OBJEKT, SAERSKILT BAOTAR.
FI895286A0 (en) FENYLOXIPROPANOLAMINER, DERAS FRAMSTAELLNING OCH TERAPEUTISKA ANVAENDNING.
FI894677A (en) BASISKA 4-ARYL-DHP-AMIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING I LAEKEMEDEL.
FI891891A0 (en) AMINOSYRAESTRAR, FOERFARANDE FOER DERAS FRAMSTAELLNING, DESSA INNEHAOLLANDE LAEKEMEDEL OCH DERAS ANVAENDNING.
FI880661A (en) VATTEN-OLJA-EMULSIONER, VILKA INNEHAOLLER AMIDAS OCH BEHANDLINGSFOERFARANDE FOER DYLIKA EMULSIONER.
FI893498A0 (en) ANORDNING FOER PRESSNING, AVVATTNING OCH FILTRERING.
FI920474A0 (en) ELEKTROPOTOGRAFISKT FRAMSTAELLD TRYCKPLATTA, MED HYDROFILA TONADE OMRAODEN OCH OLEOFILISKA OTONADE OMRAODEN.
FI890337A (en) ERGOLINDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH ANVAENDNING AV DESAMMA.
FI893699A0 (en) BIODEGRADERBAR, GIFTFRI OCH OFARLIG LOESNINGSMEDELKOMPOSITION.
FI880983A (en) VAEGGELEMENT FOER BYGGNADER, SAERSKILT FOER SKYDDSRUM OCH LIKNANDE KONSTRUKTIONER.

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: PHARMACIA & UPJOHN COMPANY